Stockholm, June 22, 2020 - Nasdaq (Nasdaq:NDAQ) announces today the updated
results of the semi-annual review of the First North 25 Index (Nasdaq
Stockholm: FN25) which will become effective with the market open on Wednesday,
July 1, 2020.
Enzymatica AB (ENZY), Faron Pharmaceuticals Oy (FARON) and Remedy Entertainment
Oyj (REMEDY) will be added to the Index.
Maha Energy AB (MAHA A), Smart Eye AB (SEYE) and Fastighets AB Trianon ser. B
(TRIAN B) will be removed from the Index.
The FN25 consists of the largest and most traded shares listed on Nasdaq First
North. Companies included in the FN25 are selected through a two-step process
as follows:
-- The 30 largest companies measured by market capitalization are selected.
-- The 25 most traded shares within this pool, measured by aggregated trading
turnover over a six month period, are selected for the index.
FN25 is reviewed semi-annually in January and July.
The First North 25 Index constituents effective July 1, 2020 are:
Absolent Group AB Minesto AB
Admicom Oyj Ovzon AB
Akelius Residential Property AB ser. D Paradox Interactive AB
Amasten Fastighets AB PowerCell Sweden AB
Cibus Nordic Real Estate AB Remedy Entertainment Oyj
Climeon AB ser. B Sdiptech AB ser. B
Detection Technology Oyj Sedana Medical AB
Embracer Group AB ser. B SpectraCure AB
Enzymatica AB Stillfront Group AB
Faron Pharmaceuticals Oy Storytel AB ser. B
Genovis AB Surgical Science Sweden AB
Kambi Group Plc Vostok Emerging Finance Ltd
Mentice AB
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital
markets and other industries. Our diverse offering of data, analytics, software
and services enables clients to optimize and execute their business vision with
confidence. To learn more about the company, technology solutions and career
opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.
Nasdaq Media Contact
David Augustsson
+46 73 449 6135
david.augustsson@nasdaq.com© 2020 GlobeNewswire
